4582 Share Price Performance
JP¥0
-171.00 (-100.00%)
Price JP¥0
Share Pricen/a
SymBio Pharmaceuticals Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
4582 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
SymBio Pharmaceuticals Limited Key Details
Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
- -81.17
- 71.86%
- -458.55%
- 443.5%
About 4582
- Founded
- 2005
- Employees
- 91
- CEO
- WebsiteView website
SymBio Pharmaceuticals Limited engages in the and development, manufacturing and sales of pharmaceuticals and other related operations in Japan and internationally. It offers SyB V-1901, an antiviral drug for post-transplant infections, blood cancers and solid tumors, and neurodegenerative diseases; SyB L-1701, an RTD liquid formulation; and SyB L-1702, an RI administration under the TREAKISYM name. The company was incorporated in 2005 and is based in Minato, Japan.
